摘要
分别采用同基因BMT及异基因BMT治愈重症再生障碍性贫血(SAA)各1例。例1经各种基因标志分析识别其与孪生兄弟为同卵双生,故采用单纯输注骨髓辅以GMCSF,使其治愈,已逾4年。例2经HLA血清学、细胞学和DRBPCR/printing配型证实与其弟HLA基因型相合,以Cy+ATG为预处理方案,移植骨髓细胞及外周血干细胞,用CSP+MTX预防GvHD,移植物于+14d植活,+61d其RBC抗原由MN转为NN供者型,现正在康复之中。
Two patients with severe aplastic anemia(SAA) treated by syngeneic BMT and allogeneic BMT plus peripheral blood stem cell transplantation (PBSCT) respectively were reported. The patient suffering from SAA Ⅱ had an identical twin brother. He received brother's marrow transfusion (1.5×10 8/kg) alone and had sustained recovery of PB counts and marrow haemopoiesis.He is alive and works normally more than 4 years. Another patient with very SAA(vSAA) and had an HLA full matched(HLA typing, cross matched MLC and DRB PCR/printing) brother as donor. He had received previous transfusion 12 times. He was administered four daily doses of Cy (50 mg/kg×4, total 200 mg/kg) alternating with three doses of ATG (25 mg/kg×3, total 75 mg/kg) followed by a HLA identical marrow graft ( 2.7×10 8 /kg,0 d) and peripheral blood stem cell ( PBSC ) transfusion ( CD34 +cells 3.85×10 5/kg,+1 d). Methotrexate (MTX) and cyclosporine A(CSP) were administered to prevent GvGH. His PMNs increased more than 0.2×10 9/L since +14 days and RBC antigen from MN became NN (donor′s source ) at +61 d. However,he was complicated with systemic MRSA infection since +12 d and followed by abscess of thoracic vertebra.The managements for abcess were effective and the patient is recovering. The article also discussed some problems with treatment of SAA.
出处
《首都医科大学学报》
CAS
1997年第2期119-121,共3页
Journal of Capital Medical University